Publishers Note: CRE very much appreciates the insights our readers have displayed in their comments and are transmitting them to Administration officials.
Ms. Valerie B. Jarrett
Senior Advisor and Assistant to the President for Intergovernmental Affairs and Public Engagement
Re: CRE’s Creation of a Kratom Scheduling Docket
Dear Ms. Jarrett:
In his Open Government Directive, President Obama called for creating and institutionalizing a “Culture of Open Government.” The President explained that to
create an unprecedented and sustained level of openness and accountability in every agency, senior leaders should strive to incorporate the values of transparency, participation, and collaboration into the ongoing work of their agency.
Last month, however, the Drug Enforcement Administration issued a Notice of Intent to place the widely used dietary supplement kratom (mitragynine and 7-hydroxymitragynine) into schedule I of the Controlled Substances Act. Thus, without any opportunity for public participation, DEA will be criminalizing a substance that is not only widely used in the United States but also is used in and will continue to be legal in Canada and Mexico.